New cancer vaccine shows promising results for certain patients
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
Boise State Public Radio1d
She wanted to be a mom. So she chose a cancer treatment that gave her a chance
New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after ...
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
EurekAlert!3d
Dana-Farber researchers present findings at 2025 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
Cancer vaccine shows promise for patients with stage III and IV kidney cancer
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
EurekAlert!2d
Dana-Farber researchers to present key transplant and cellular therapy studies at 2025 tandem meetings
Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier conference in hematopoietic cell transplantation (HCT) and cellular therapy.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Armed robbery in Revesby1d
Dana-Farber Unveils Key Transplant Studies at 2025 Event
Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier ...
Harvard Medical School8d
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
New Vaccine Shows Promise For Kidney Cancer
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...